58160-849Level 3
Shingrix (Zoster Vaccine Recombinant, Adjuvanted)
**Product type:** Vaccine
**Active ingredient:** RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
**Strength:** 50 ug/.5mL
**Dosage form:** Injection, Solution
**Route:** Intramuscular
**Labeler:** GlaxoSmithKline Biologicals SA
**Marketing category:** BLA (BLA125614)
GET
/api/v1/systems/ndc_fda/nodes/58160-849Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.